STERIS plc revenue by segment STE

Annual Quarterly

STERIS plc splits its revenue 2 ways in its filings. By operating segments, the largest line in Q2 of fiscal 2027, the quarter ended Sep 30, 2026 was Healthcare at $1.1 billion, 71% of the total. By sales mix, the largest line in Q2 of fiscal 2027, the quarter ended Sep 30, 2026 was Services at $771.7 million, 49% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Sep 30, 2026	Q2 FY2027 Sep 30, 2026	Q1 FY2027 Jun 30, 2026	Q4 FY2026 Mar 31, 2026	Q3 FY2026 Dec 31, 2025	Q2 FY2026 Sep 30, 2025	Q1 FY2026 Jun 30, 2025	Q4 FY2025 Mar 31, 2025	Q3 FY2025 Dec 31, 2024
Revenue	6,166	1,589	1,493	1,588	1,496	1,460	1,391	1,480	1,371
Operating segments
Healthcare	—	1,122 +8.6% share 70.7%	1,048 +7.6% share 70.2%	1,136 +7.5% share 71.5%	1,064 +9.0% share 71.1%	1,034 share 70.8%	975 share 70.1%	1,057 share 71.4%	976 share 71.2%
Applied Sterilization Technologies	—	296 +5.0% share 18.6%	298 +5.8% share 19.9%	289 +5.6% share 18.2%	287 +11.0% share 19.2%	282 share 19.3%	281 share 20.2%	274 share 18.5%	258 share 18.8%
Life Science	—	171 +17.7% share 10.7%	147 +8.5% share 9.8%	—	146 +6.9% share 9.7%	145 share 9.9%	135 share 9.7%	—	136 share 10.0%
Sales mix
Services	2,988 +8.8% share 48.5%	772 +7.9% share 48.6%	756 +7.8% share 50.6%	743 +9.4% share 46.8%	717 +10.0% share 47.9%	715 share 49.0%	701 share 50.4%	680 share 45.9%	652 share 47.6%
Servicerevenues	1,694 +10.1% share 27.5%	441 +10.1% share 27.7%	426 +9.6% share 28.5%	423 +9.4% share 26.6%	405 +11.5% share 27.0%	400 share 27.4%	388 share 27.9%	386 share 26.1%	363 share 26.5%
Consumablerevenues	1,567 +8.5% share 25.4%	412 +10.0% share 25.9%	392 +9.2% share 26.3%	376 +6.7% share 23.7%	387 +8.1% share 25.9%	374 share 25.6%	359 share 25.8%	353 share 23.8%	358 share 26.1%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as: STE (NYSE)
Fiscal year ends: March 31
Incorporated in: Ireland
Headquarters: Dublin, Ireland
SEC filer status: Large accelerated filer
SEC CIK: 1757898
Former names: STERIS Ltd (until Mar 28, 2019)

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.